Home > Products > Primary Cells > Human Primary Cells > Immune System Primary Cells >
Human Chronic Lymphoid Leukemia PB CD19+/CD5+ B Cells (Newly Diagnosed/Untreated) |
||||
---|---|---|---|---|
Product Name |
Human Chronic Lymphoid Leukemia PB CD19+/CD5+ B Cells (Newly Diagnosed/Untreated) |
|||
Price | Get Quote | |||
Cat.No |
ABC-TC3346 |
Species |
Human |
|
Size/Quantity |
1 vial |
Biosafety Level |
1 |
|
Shipping Info |
Dry Ice |
Storage |
Liquid Nitrogen |
|
Description |
Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia peripheral blood mononuclear cells using a direct immunomagnetic CD19+ MicroBead labeling system. Available in untreated or relapsed/refractory stages. |
|||
Disease | Chronic Lymphoid Leukemia |
|||
Source Organ | Peripheral Blood |
|||
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
|||
Citation Guide |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). |
|||
Application | For research use only |
|||
Growth Conditions | 37 ℃, 5% CO2 |
|||
Cell Type | B Cell |
|||
Growth Mode | Suspension |
|||
Product Type |
Immune Cells |
|||
Product Image |
![]() |
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.